Meningitis

Show: All Sections A Piece of My Mind Book and Media Reviews Brief Reports Capitol Health Call Care of the Aging Patient Caring for the Critically Ill Patient Clinical Crossroads Clinical Reviews Commentaries Controversies Editorials From the Archives Journals: Abstracts and Commentary From the Centers for Disease Control and Prevention Grand Rounds Health Law and Ethics JAMA Classics JAMA Patient Page Letters Literatim Medical News & Perspectives News and Analysis On Call Original Contributions Perspectives on Care at the Close of Life Poetry and Medicine Preliminary Communications Research Letters Reviews Special Communications The Cover The Patient-Physician Relationship The Rational Clinical Examination This Week in JAMA Users' Guides to the Medical Literature

Displaying results 1-10 of 41

Most recent content (February 8, 2012):

• Original Contributions:

  Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization Schedules: A Randomized Controlled Trial

  • Nicoletta Gossger,
  • Matthew D. Snape,
  • Ly-Mee Yu,
  • Adam Finn,
  • Gianni Bona,
  • Susanna Esposito,
  • Nicola Principi,
  • Javier Diez-Domingo,
  • Etienne Sokal,
  • Birgitta Becker,
  • Dorothee Kieninger,
  • Roman Prymula,
  • Peter Dull,
  • Ellen Ypma,
  • Daniela Toneatto,
  • Alan Kimura,
  • Andrew J. Pollard,
  • for the European MenB Vaccine Study Group

  JAMA. 2012;307(6):573-582.doi:10.1001/jama.2012.85
  • Abstract
  • Full Text
  • Full Text (PDF)
  • eSupplement
• Editorials:

  Inching Toward a Serogroup B Meningococcal Vaccine for Infants

  • Amanda C. Cohn,
  • Nancy E. Messonnier

  JAMA. 2012;307(6):614-615.doi:10.1001/jama.2012.118
  • Extract
  • Full Text
  • Full Text (PDF)

Past content (since February 1998):

• From the Centers for Disease Control and Prevention:

  Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease—Advisory Committee on Immunization Practices (ACIP), 2011

  JAMA. 2012;307(1):27-28.
  • Extract
  • Full Text
  • Full Text (PDF)
• From the Centers for Disease Control and Prevention:

  Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D)Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease

  JAMA. 2011;306(20):2211-2212.
  • Extract
  • Full Text
  • Full Text (PDF)
• From the Centers for Disease Control and Prevention:

  Updated Recommendations for Use of Meningococcal Conjugate Vaccines—Advisory Committee on Immunization Practices (ACIP), 2010

  JAMA. 2011;305(13):1291-1293.
  • Extract
  • Full Text
  • Full Text (PDF)
• From the Centers for Disease Control and Prevention:

  Occupational Transmission of Neisseria meningitidis—California, 2009

  JAMA. 2011;305(1):29-32.
  • Extract
  • Full Text
  • Full Text (PDF)
• Health Agencies Update:

  Lamotrigine Warning

  • Bridget M. Kuehn

  JAMA. 2010;304(12):1317doi:10.1001/jama.2010.1332
  • Extract
  • Full Text
  • Full Text (PDF)
• From the Centers for Disease Control and Prevention:

  Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use—Advisory Committee on Immunization Practices (ACIP), 2010

  JAMA. 2010;304(1):38
  • Extract
  • Full Text
  • Full Text (PDF)
• From the Centers for Disease Control and Prevention:

  Bacterial Meningitis After Intrapartum Spinal Anesthesia—New York and Ohio, 2008-2009

  JAMA. 2010;303(11):1026-1028.
  • Extract
  • Full Text
  • Full Text (PDF)
• From the Centers for Disease Control and Prevention:

  West Nile Virus Activity—United States, 2007

  JAMA. 2008;300(12):1406-1408.doi:10.1001/jama.300.12.1406
  • Extract
  • Full Text
  • Full Text (PDF)